OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathy
Nazish Sayed, Chun Liu, Mohamed Ameen, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 554
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging
Nazish Sayed, Yingxiang Huang, Khiem Van Nguyen, et al.
Nature Aging (2021) Vol. 1, Iss. 7, pp. 598-615
Open Access | Times Cited: 370

Statins improve endothelial function via suppression of epigenetic-driven EndMT
Chun Liu, Mengcheng Shen, Wilson Lek Wen Tan, et al.
Nature Cardiovascular Research (2023) Vol. 2, Iss. 5, pp. 467-485
Open Access | Times Cited: 45

Advancements of 3D bioprinting in regenerative medicine: Exploring cell sources for organ fabrication
Yue Ma, Bo Deng, Runbang He, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24593-e24593
Open Access | Times Cited: 20

Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis
Meiming Su, Wenqi Zhao, Hui Jiang, et al.
Nature Cardiovascular Research (2025)
Closed Access | Times Cited: 5

Arrhythmias as Presentation of Genetic Cardiomyopathy
James L. Laws, Megan Lancaster, M. Ben Shoemaker, et al.
Circulation Research (2022) Vol. 130, Iss. 11, pp. 1698-1722
Open Access | Times Cited: 55

Cellular and Engineered Organoids for Cardiovascular Models
Dilip Thomas, Suji Choi, Christina Alamana, et al.
Circulation Research (2022) Vol. 130, Iss. 12, pp. 1780-1802
Open Access | Times Cited: 51

Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy
Yansong Tang, Mengying Feng, Yang Su, et al.
Circulation (2023) Vol. 147, Iss. 22, pp. 1684-1704
Open Access | Times Cited: 37

SGLT2 inhibitor ameliorates endothelial dysfunction associated with the commonALDH2alcohol flushing variant
Hongchao Guo, Xuan Yu, Yu Liu, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 680
Open Access | Times Cited: 30

Endothelial cell dysfunction in cardiac disease: driver or consequence?
Jules D. Allbritton‐King, Guillermo Garcı́a-Cardeña
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28

Deciphering potential vascularization factors of on-chip co-cultured hiPSC-derived cerebral organoids
Maneesha Shaji, Atsushi Tamada, Kazuya Fujimoto, et al.
Lab on a Chip (2024) Vol. 24, Iss. 4, pp. 680-696
Open Access | Times Cited: 13

The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions
Vikas Tiwari, Md Jahangir Alam, M L Bhatia, et al.
Life Sciences (2024) Vol. 341, pp. 122489-122489
Closed Access | Times Cited: 9

Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production
Dilip Thomas, Nathan James Cunningham, Sushma Shenoy, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 1, pp. 20-36
Open Access | Times Cited: 56

Lamin A/C-dependent chromatin architecture safeguards naïve pluripotency to prevent aberrant cardiovascular cell fate and function
Yinuo Wang, Adel Elsherbiny, Linda Kessler, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 32

FDA Modernization Act 2.0 Paves the Way to Computational Biology and Clinical Trials in a Dish
Syed Mukhtar Ahmed, Rabindra V. Shivnaraine, Joseph C. Wu
Circulation (2023) Vol. 148, Iss. 4, pp. 309-311
Open Access | Times Cited: 21

Tissue‐Engineered Microvessels: A Review of Current Engineering Strategies and Applications
Nan Zhao, Alexander F. Pessell, Ninghao Zhu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 21
Closed Access | Times Cited: 7

Clinical trials in-a-dish for cardiovascular medicine
Xuekun Wu, Kyle Swanson, Zehra Yıldırım, et al.
European Heart Journal (2024)
Closed Access | Times Cited: 7

The American Heart Association at 100: A Century of Scientific Progress and the Future of Cardiovascular Science: A Presidential Advisory From the American Heart Association
Mitchell S.V. Elkind, Donna K. Arnett, Ivor J. Benjamin, et al.
Circulation (2024) Vol. 149, Iss. 12
Closed Access | Times Cited: 6

A call to action for new global approaches to cardiovascular disease drug solutions
Gemma A. Figtree, Keith Broadfoot, Barbara Casadei, et al.
European Heart Journal (2021) Vol. 42, Iss. 15, pp. 1464-1475
Open Access | Times Cited: 41

Sources and applications of endothelial seed cells: a review
Dan Deng, Yu Zhang, Bo Tang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

The LINC Between Mechanical Forces and Chromatin
Olga Lityagina, Gergana Dobreva
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 31

Clinical Trial in a Dish
Chi Keung Lam, Joseph C. Wu
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 3, pp. 1019-1031
Open Access | Times Cited: 30

Tackling the challenges of new approach methods for predicting drug effects from model systems
Paul Pang, Syed Mukhtar Ahmed, Masataka Nishiga, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 565-566
Closed Access | Times Cited: 4

Generation of induced pluripotent stem cell line from a patient with long COVID
David Wu, Amit Manhas, Chikage Noishiki, et al.
Stem Cell Research (2025) Vol. 83, pp. 103652-103652
Open Access

Page 1 - Next Page

Scroll to top